Rating: HOLD
HOLD (5-tier) · quality defensive · conviction: medium
| Metric | Value |
|---|---|
| Current Price | $176 |
| Triangulated Fair Value | $141 (-20% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $171 (-3% vs spot · 12m PWEV) |
| Forward P/E | 21.2x |
| Market Cap | $36B |
| 52-Week Range | $155–$238 |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Investment Committee Summary
| Rating | HOLD · HOLD (5-tier) |
| Classification · conviction | quality defensive · medium |
| Triangulated fair value | $141 (-20% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $171 (-3% vs spot · 12m PWEV) |
| Next catalyst | 2026-02-05 — FY25 results + FY26 EPS guide amid cocoa-cost normalization |
| Primary thesis-break | Organic volume growth (North America Confectionery) < -4% YoY (2 consecutive prints) |
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Rating Bridge
Rating = HOLD because:
- Probability-weighted scenario value implies -3% vs spot
- Monte Carlo median implies -9% vs spot
- DCF fair value implies -30% vs spot
- Bear case (Structural — GLP-1 / Private-Label Erosion) downside is -58% vs spot
- Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.
Investment Thesis
At $175.45 on a forward multiple near 21 times, the market prices HSY as a durable staples compounder whose pricing and mix offset soft volume and a normalising cocoa-cost cycle. The engine is more cautious. The probability-weighted target of $174.09 sits fractionally below spot, driven by a 24% weight on structural GLP-1 and private-label erosion whose target ($74.68) sits under the 52-week low of $155.42, and by a Monte Carlo in which the P/E multiple and gross margin account for roughly 96% of variance. The base case ($8.83 EPS at 21.5 times) still clears $190, but the disconfirmation signal flags management running unusually upbeat versus the analyst floor. The rating is HOLD: mid-cycle earnings support today's price, yet the multiple leaves no margin of safety against the structural tail. The single most damaging risk is GLP-1-driven confectionery volume decline compounding private-label trade-down, which would compress both earnings and the multiple at once.
The dashboard below is the whole argument on one page: spot ($176) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The highest-probability bear is not the tail but the base-adjacent cyclical case, with structural erosion the largest single weight at 24%. Its mechanism is concrete. GLP-1 adoption durably lowers snacking occasions in HSY's core US chocolate category while cash-constrained consumers trade into private label, eroding the volume and pricing that underwrite a 21-times multiple. Cocoa input costs stay elevated, so gross margin cannot recover on schedule, and a staples name that misses on both volume and margin de-rates toward a value-food multiple. At -10% growth, a 13.5% margin and a 12.8-times multiple, the implied target of roughly $73 sits below the 52-week low. The 41.7% Monte Carlo probability of exceeding spot leaves this outcome uncomfortably live.
Key Debate
P/E Multiple explains 55% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.59 vs analyst floor +0.00 → delta +0.59 (n=40 mgmt / 34 Q&A; 86th pctile across the S&P book, z +1.2).
Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.59 | +0.00 | +0.59 |
| 2025Q4 | +0.34 | +0.09 | +0.25 |
| 2025Q3 | +0.35 | +0.18 | +0.17 |
| 2025Q2 | +0.44 | +0.31 | +0.13 |
News (last 365d, 1000 articles): avg ticker sentiment +0.18 (bullish 28% / bearish 3%)
Scenario Analysis
The tree runs from a structural 'Structural — GLP-1 / Private-Label Erosion' downside ($73) to a 'Bull — Margin Recovery / Re-Rate' bull case ($300); the probability-weighted blend (PWEV $171) is -3% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — GLP-1 / Private-Label Erosion | 24% | $73 | -58% |
| Volume / Cost Recession | 18% | $142 | -19% |
| Base — Price/Mix Offsets Volume | 32% | $190 | +8% |
| Growth — Snacking + Premiumization | 18% | $242 | +38% |
| Bull — Margin Recovery / Re-Rate | 8% | $300 | +70% |
| Probability-Weighted (PWEV) | — | $171 | -3% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — GLP-1 / Private-Label Erosion (24%, $73). Structural impairment — GLP-1 / private-label erosion: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 74.68; probability: 0.24.
- Volume / Cost Recession (18%, $142). Cyclical downturn — packaged-food volume + price/mix vs private-label + GLP-1 + input costs weakens for 1–2 years before normalising. Drivers — implied_target: 142.42; probability: 0.18.
- Base — Price/Mix Offsets Volume (32%, $190). Mid-cycle — normalised packaged-food volume + price/mix vs private-label + GLP-1 + input costs; disciplined capital allocation; steady returns. Drivers — implied_target: 192.98; probability: 0.32.
- Growth — Snacking + Premiumization (18%, $242). Upside — snacking + premiumization + margin recovery lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 247.78; probability: 0.18.
- Bull — Margin Recovery / Re-Rate (8%, $300). Upside tail — sustained tight conditions or a structural re-rate on snacking + premiumization + margin recovery. Drivers — implied_target: 302.2; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $160 | -9% |
| Peer P/E re-rate | multiple | $100 | -43% |
| Peer EV/Revenue re-rate | multiple | $81 | -54% |
| Scenario PWEV | multiple | $171 | -3% |
| DCF (5-year + terminal) | cash flow + terminal × | $124 | -30% |
| Triangulated (weighted) | — | $141 | -20% |
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $160 + scenario PWEV $171, ≈ spot); the weighted blend $141 (-20%) sits below it because the cash-flow DCF ($124) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $160 and 41% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (55% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 8.0%, 18x terminal FCF multiple → $124. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 12.085x) implies $100. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is 73% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Packaged Foods | $12.0B | 100% | 2% | 18% | $2.2B | 21x | 4% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | packaged-food volume + price/mix vs private-label + GLP-1 + input costs |
| net_debt_or_cash_b | -4.48 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.04 |
| div_yield | 0.0304 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | GLP-1 / private-label erosion |
| upside | snacking + premiumization + margin recovery |
Industry Context — Consumer Staples — Food Bev
This name sits in the Consumer Staples — Food Bev as a packaged_food. packaged-food volume + price/mix vs private-label + GLP-1 + input costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: KO (beverages) · PEP (beverages) · MNST (beverages) · MDLZ (packaged_food) · KDP (beverages) · HSY (packaged_food) · KHC (packaged_food) · GIS (packaged_food) · HRL (packaged_food) · MKC (packaged_food) · SJM (packaged_food) · CAG (packaged_food)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Structural — GLP-1 / Private-Label Volume Hit | 40% | 42% | |
| Mid-Cycle — Price/Mix Offsets Volume | 33% | 32% | |
| Upside — Premiumization / EM Growth | 27% | 26% |
Mapping note: name-level 'Structural — GLP-1 / Private-Label Erosion' (24%) + 'Volume / Cost Recession' (18%) map to cluster Structural — GLP-1 / Private-Label Volume Hit (42%); name-level 'Growth — Snacking + Premiumization' (18%) + 'Bull — Margin Recovery / Re-Rate' (8%) map to cluster Upside — Premiumization / EM Growth (26%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.
On the cluster's key downside — Structural — GLP-1 / Private-Label Volume Hit () — this name implies 42% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_food_bev cycle is the shared macro driver. Driver — food & beverage volume + price/mix vs private-label + GLP-1 + input costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $12B | $2B | $1B | $1B | $2B | $2B |
| FY+2 | $12B | $2B | $1B | $1B | $2B | $1B |
| FY+3 | $13B | $2B | $1B | $1B | $2B | $1B |
| FY+4 | $13B | $2B | $1B | $1B | $2B | $1B |
| FY+5 | $13B | $2B | $1B | $1B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 18x | $23B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.0% · Σ PV(FCF) $7B + PV(terminal) $23B = EV $30B; + net cash → equity $25B ÷ diluted shares 0.20B = $124/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $128/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 8% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| MDLZ | 2.51x | 20.2x | 2% | 9% |
| KHC | 1.77x | 11.25x | 2% | 21% |
| TSN | 0.501x | 12.92x | 2% | 4% |
| GIS | 1.728x | 10.85x | 2% | 19% |
| Median | 1.749x | 12.085x | — | — |
Peer-median fwd P/E → $100; EV/Rev → $81.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $124 | 41% | $51 |
| Scenario PWEV | $171 | 29% | $50 |
| Monte Carlo median | $160 | 18% | $28 |
| Peer P/E | $100 | 12% | $12 |
| Triangulated | — | 100% | $141 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC \ Term× | 12.6x | 15.3x | 18.0x | 20.7x | 23.4x |
|---|---|---|---|---|---|
| 6% | $100 | $118 | $136 | $155 | $173 |
| 7% | $95 | $112 | $130 | $147 | $165 |
| 8% | $90 | $107 | $124 | $140 | $157 |
| 9% | $86 | $102 | $118 | $134 | $150 |
| 10% | $82 | $97 | $112 | $127 | $142 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ \ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $84 | $94 | $105 | $116 | $126 |
| -1.5pp | $91 | $103 | $114 | $125 | $137 |
| +0.0pp | $99 | $112 | $124 | $136 | $148 |
| +1.5pp | $108 | $121 | $134 | $147 | $159 |
| +3.0pp | $117 | $131 | $144 | $158 | $172 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $99 | $148 | $48 |
| Revenue CAGR ±3pp | $105 | $144 | $39 |
| Terminal × ±15% | $107 | $140 | $33 |
| Capex intensity ±15% | $117 | $131 | $14 |
| WACC ±1pp | $118 | $130 | $12 |
Company lever — SoP/share vs Packaged Foods multiple (AI re-rating) (base 21x)
| Multiple | 14.7x | 17.8x | 21.0x | 24.1x | 27.3x |
|---|---|---|---|---|---|
| SoP/share | $847 | $1,030 | $1,219 | $1,403 | $1,592 |
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $216 (+23% vs spot · street) |
| House target | $174 (-19.4% vs street) |
| Sell-side coverage | 23 analysts (SB 3 / B 5 / H 14 / S 1 / SS 0; net score 0.22) |
| Consensus FY EPS | $9.90; house below (-16.3%) |
| Consensus FY revenue | $12.6B; house below (-3.1%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $4.5B — levered |
| Net debt / EBITDA | 1.98x |
| Interest coverage (EBIT / interest) | 7.0x |
| Current ratio | 1.19x |
| Lease obligations | $0.4B |
| Cash & ST investments | $0.9B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $1.7B |
| Buybacks / dividends | $0.0B / $1.1B |
| Total shareholder yield | 3.1% |
| Payout as % of FCF | 63.2% |
| Reinvestment (capex / OCF) | 23.2% |
| SBC as % of FCF | 3.7% |
| Allocation stance | balanced |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 14.6% |
| FCF conversion (FCF / net income) | 198.1% |
| FCF yield | 4.9% |
| Capex intensity (capex / revenue) | 4.4% |
| FCF − SBC (diagnostic) | $1.7B |
| Capex split (maint / growth) | 60% / 40% — Capital-light branded compounder; growth capex funds capacity expansion, salty-snack integration and ERP/automation on top of plant maintenance. |
Accounting quality: SBC 0.5% of revenue; cash conversion (OCF/NI) 258% — cash-backed.
Catalyst Calendar
- 2026-02-05 (~-153d) — FY25 results + FY26 EPS guide amid cocoa-cost normalization (authored)
- 2026-07-23 (~15d) — Q2 FY26 volume elasticity + salty-snack growth update (authored)
- 2026-07-29 (~21d) — Quarterly earnings — est. EPS $1.46 (AV EARNINGS_CALENDAR)
- 2026-10-20 (~104d) — Halloween / seasonal-chocolate sell-through and cocoa-cost pass-through (authored)
Forecast Track Record
- EPS surprise: beat 75.0% of the last 8 quarters; average surprise +10.1%.
Competitive Moat
Wide moat. Hershey's ~45% US chocolate share, dominant shelf space and iconic brands give durable pricing power that supports a premium ~20-21x terminal multiple; but the moat is category-specific — if GLP-1 and private-label structurally shrink US chocolate demand, even a wide moat cannot defend a premium multiple and it should compress toward the staples ~16-17x median, falsifiable by sustained branded chocolate volume declines.
Moat sources:
- ~45% US chocolate market share and category-captain shelf dominance
- Iconic brands (Hershey's, Reese's, Kisses) with high repeat purchase and pricing power
- Scale manufacturing + distribution moat in a concentrated category (vs Mars)
- Salty-snack diversification (SkinnyPop, Dot's) extending the platform
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Cocoa commodity / West-Africa supply and potential deforestation-import (EUDR-style) rules | medium (~40%) | high - cocoa is the dominant COGS input, ~6% of FV | 12-24m |
| Sugar/added-sugar labeling and processed-food health scrutiny (FDA/state) | low (~25%) | low - gradual, ~2% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — GLP-1 / Private-Label Erosion | GLP-1 adoption durably suppresses discretionary sugar/snacking demand and private label erodes branded chocolate share; even the category leader loses pricing power. | US chocolate volume enters structural decline while pricing exhausts — target below the 52-week low. |
| Volume / Cost Recession | Consumer trade-down plus sustained record cocoa costs squeeze gross margin through a soft-volume recession. | Cocoa inflation persists and pricing elasticity finally breaks volume, compressing margin. |
| Base — Price/Mix Offsets Volume | Pricing/mix offsets soft volume, cocoa costs normalize gradually; ~$8.83 EPS at ~21.5x. | Cocoa stays elevated longer than hedges cover and volume elasticity worsens. |
| Growth — Snacking + Premiumization | Salty-snacks and premium/seasonal mix drive above-category growth with margin expansion as cocoa normalizes. | Snacking integration underdelivers or promotional intensity caps margin. |
| Bull — Margin Recovery / Re-Rate | Cocoa costs fully normalize, gross margin recovers, and the market re-rates HSY as a durable pricing-power compounder. | Re-rating assumes GLP-1/private-label do not structurally impair the core — the key disconfirmation. |
What the Market Is Pricing In
At the current price, the market pays 17.8× forward EPS, vs the house DCF terminal 18.0×, and a peer median 12.085×. The house DCF sits 30% below spot, so the market is pricing in more than the house case — roughly 2.8pp of revenue CAGR.
Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 12.6 | 12.2 | High |
| EPS | 9.9 | 8.3 | Medium |
| Target price | 215.9 | 174.1 | Medium |
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| MDLZ | 20.2× | 2% | 9% | direct | 100% |
| KHC | 11.25× | 2% | 21% | segment | 50% |
| TSN | 12.92× | 2% | 4% | segment | 50% |
| GIS | 10.85× | 2% | 19% | segment | 50% |
Quality-weighted forward P/E: 15.1× (simple median 12.085×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $155–$238, centre $192 (+9% vs spot); spot sits at the 25th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $141 (-20% vs spot · triangulated FV) |
| Downside to bear case (Structural — GLP-1 / Private-Label Erosion) | $73 (-58% vs spot · bear scenario) |
| Reward/risk ratio | 0.3× |
| Margin of safety (FV vs spot) | -24% |
| P(price > spot) — Monte Carlo | 41% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Margin Recovery / Re-Rate): $300.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| WACC | 8.0% | DCF discount rate | estimate (CAPM) |
| Terminal multiple | 18× | DCF exit value | estimate (peer-anchored) |
| Terminal growth | 2.5% | DCF Gordon terminal | estimate |
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (48.0); Revenue CAGR ±3pp (39.0); Terminal × ±15% (33.0); Capex intensity ±15% (14.0); WACC ±1pp (12.0).
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $12.0B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $12.2B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $9.9014 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.204B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $4.477B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
| WACC | 8.0% | house estimate | CAPM (beta/rf) | Medium | DCF discount rate |
| Terminal multiple | 18× | house estimate | Peer/historical range | Medium | DCF exit value |
| Terminal growth | 2.5% | house estimate | Long-run GDP+ | Medium | DCF Gordon terminal |
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-07-08 | Price, market cap, EV, 52-week range, forward P/E | Alpha Vantage 2026-06-26 |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-07-08 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-07-08 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-07-08 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-07-08 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-07-08 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-07-08 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-07-08 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-07-08 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 18×, FY+5 revenue $13B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Organic volume growth (North America Confectionery) < -4% YoY (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Sustained volume declines below the cyclical range would corroborate GLP-1 appetite suppression and private-label trade-down rather than a transient destock; the base case assumes price/mix offsets roughly flat volume.
- Adjusted gross margin < 40% (2 consecutive prints → Volume / Cost Recession). A gross margin sustained below the low-40s would signal cocoa input costs are not being recovered through pricing or hedges, undermining the margin-normalisation path embedded in the base and growth scenarios.
- Full-year adjusted EPS guidance < $8.00 (single event → Volume / Cost Recession). A guide beneath roughly the midpoint of the base ($8.83) and recession ($7.67) EPS paths would place the earnings base closer to the cyclical scenario, removing the support under the mid-cycle target.
- Private-label unit share in US chocolate > +150bps YoY (2 consecutive prints → Structural — GLP-1 / Private-Label Volume Hit). Accelerating private-label share gains would evidence structural erosion of HSY's pricing power and brand moat, the mechanism behind the sub-52-week-low structural target.
- Capital expenditure > $0.75B annualised (2 consecutive prints → Base — Price/Mix Offsets Volume). Capex reverting toward the FY2023 peak ($771m) without a commensurate revenue step-up would compress free cash flow and signal the capital-light glidepath ($0.53–$0.59B) has broken, weakening the DCF anchor.
Fact / Inference / Speculation
- FACT: Spot $176; 52-week range $155–$238; engine rating HOLD; base-case target $174 (-1%). (source: Alpha Vantage 2026-06-26, 8 July 2026)
- INFERENCE: Triangulated FV $141 (-20% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Recommendation: HOLD
Balanced: triangulated fair value $141 (-20% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.